Home
September 2008 October 2008 November 2008
Su Mo Tu We Th Fr Sa
Week 40 1 2 3 4
Week 41 5 6 7 8 9 10 11
Week 42 12 13 14 15 16 17 18
Week 43 19 20 21 22 23 24 25
Week 44 26 27 28 29 30 31

Comparative in Vivo Uroselectivity Profiles of Anticholinergics, Tested in a Novel Anesthetized Rabbit Model – Abstract Show Comments PDF Print E-mail
  
Monday, 22 October 2007
Department of Pharmacology, Ranbaxy Research Laboratories, Plot-20, Sector-18, Gurgaon 122 015, India

The aim of this study was to describe a new experimental animal model for simultaneous measurement of carbachol-induced increase in intravesical pressure and salivary secretion in rabbits. Further, we also compared the in vivo potency and urinary bladder versus salivary gland selectivity profiles of Oxybutynin, Tolterodine, Solifenacin and Darifenacin. The intravesical pressure and salivary secretion were evoked by intra-arterial injection of carbachol (1.5 mug/kg). The carbachol-induced increase in intravesical pressure and salivation was simultaneously recorded before and after increasing doses of test drugs administered intravenously. The basal mean changes in intravesical pressure and salivation subsequent to carbachol administration were in the range of 6.7-7.5 mm Hg and 0.5-0.7 g respectively. Repeated administration of vehicle did not elicit any appreciable changes in intravesical pressure and salivary secretion to carbachol administration from the basal values till 3 h. All the test drugs exhibited a dose-dependent inhibition of carbachol-induced increase in intravesical pressure and salivary secretion. Darifenacin demonstrated a greater potency compared to other muscarinic receptor antagonists for inhibiting carbachol-induced increase in intravesical pressure. It also exhibited functional selectivity for the urinary bladder versus salivary gland. In contrast, Oxybutynin was functionally more selective in inhibiting carbachol-induced increase in salivary secretion. The observed urinary bladder versus salivary selectivity values were 0.6+/-0.2, 1.1+/-0.2, 1.7+/-0.5, and 2.3+/-0.5 for Oxybutynin, Tolterodine, Solifenacin and Darifenacin respectively. These results suggest that the functional selectivity of muscarinic receptor antagonists between urinary bladder and salivary glands can be readily detected in this model. Thus rabbits may represent a useful animal model for evaluating putative bladder selective muscarinic receptor antagonists for the treatment of overactive bladder.

Written by
Naruganahalli KS, Sinha S, Hegde LG, Meru AV, Chugh A, Kumar N, Gupta JB, Ray A.

Reference
Eur J Pharmacol. 2007 Oct 31;572(2-3):207-12.
doi:10.1016/j.ejphar.2007.06.009

PubMed Abstract
PMID: 17610864

UroToday.com Overactive Bladder Section

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 
< Prev   Next >